<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39367210</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-0259</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Cardiovascular toxicology</Title><ISOAbbreviation>Cardiovasc Toxicol</ISOAbbreviation></Journal><ArticleTitle>LncRNA MALAT1 to Enhance Pyroptosis in Viral Myocarditis Through UPF1-Mediated SIRT6 mRNA Decay and Wnt-β-Catenin Signal Pathway.</ArticleTitle><Pagination><StartPage>1439</StartPage><EndPage>1454</EndPage><MedlinePgn>1439-1454</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12012-024-09922-w</ELocationID><Abstract><AbstractText>Viral myocarditis (VMC) is an inflammatory disease of the myocardium caused by cardioviral infection, especially coxsackievirus B3 (CVB3), and is a major contributor to acute heart failure and sudden cardiac death in children and adolescents. LncRNA MALAT1 knockdown reportedly inhibits the differentiation of Th17 cells to attenuate CVB3-induced VMC in mice. Moreover, long non-coding RNAs (lncRNAs) interact with RNA-binding proteins (RBPs) to regulate UPF1-mediated mRNA decay. However, it remains unclear whether MALAT1 can bind to UPF1 to mediate the mRNA decay of its target genes in VMC. Herein, we aimed to explore the effect of lncRNA MALAT1 on UPF1-mediated SIRT6 mRNA decay in VMC using in vivo and in vitro experiments. CVB3-infected BABL/C mice were used as VMC models, and MALAT1 interfering adenovirus was injected to achieve MALAT1 knockdown. The heart function of the VMC mice was assessed using echocardiography. Pathological changes in myocardial tissues were assessed after hematoxylin-eosin staining. Myocardial injury and inflammation were evaluated by measuring creatine kinase isoenzyme B, cardiac troponin T, interleukin (IL)-1β, and IL-18. TUNEL staining was performed to assess apoptosis in myocardial tissues. In vitro experiments were performed using H9c2 cells after transfection and CVB3 infection. The lactic dehydrogenase release, caspase-1 activity, and IL-1β and IL-18 levels in the cellular supernatant were detected. Western blotting was performed to determine the expression of pyroptosis-related proteins (GSDMD-N, NLRP3, ASC, and Cleaved-Caspase-1) and Wnt/β-catenin signal pathway-related proteins (Wnt1, β-catenin, and p-GSK-3β). RNA immunoprecipitation and RNA stability assays assessed the relationship between MALAT1, UPF1, and SIRT6. CVB3-infected mice and H9c2 cells exhibited elevated MALAT1 and reduced SIRT6 expression. MALAT1 knockdown or SIRT6 overexpression suppressed inflammation and pyroptosis and inhibited the activation of the Wnt/β-catenin signal pathway in myocardial tissues and cells. MALAT1 enhanced the enrichment of SIRT6 mRNA by UPF1 and disturbed the stability of SIRT6 mRNA to promote the development of VMC. MALAT1 can bind UPF1 to mediate SIRT6 mRNA decay and activate the Wnt/β-catenin signal pathway in VMC.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University (Hunan Children's Hospital), No. 86 Ziyuan Road, Yuhua District, Changsha, Hunan, 410007, People's Republic of China. zengmin_cs@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University (Hunan Children's Hospital), No. 86 Ziyuan Road, Yuhua District, Changsha, Hunan, 410007, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yefeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University (Hunan Children's Hospital), No. 86 Ziyuan Road, Yuhua District, Changsha, Hunan, 410007, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhou</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University (Hunan Children's Hospital), No. 86 Ziyuan Road, Yuhua District, Changsha, Hunan, 410007, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Jinxing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University (Hunan Children's Hospital), No. 86 Ziyuan Road, Yuhua District, Changsha, Hunan, 410007, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University (Hunan Children's Hospital), No. 86 Ziyuan Road, Yuhua District, Changsha, Hunan, 410007, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University (Hunan Children's Hospital), No. 86 Ziyuan Road, Yuhua District, Changsha, Hunan, 410007, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023JJ30318; 2024JJ9349</GrantID><Agency>Natural Science Foundation of Hunan Province</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cardiovasc Toxicol</MedlineTA><NlmUniqueID>101135818</NlmUniqueID><ISSNLinking>1530-7905</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C557040">Malat1 long non-coding RNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.1.-</RegistryNumber><NameOfSubstance UI="D037761">Sirtuins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.2.31</RegistryNumber><NameOfSubstance UI="C501860">Sirt6 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015534">Trans-Activators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495267">CTNNB1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051176">beta Catenin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="Y">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069292" MajorTopicYN="Y">Pyroptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020871" MajorTopicYN="Y">RNA Stability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037761" MajorTopicYN="Y">Sirtuins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="Y">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060449" MajorTopicYN="Y">Wnt Signaling Pathway</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="Y">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020365" MajorTopicYN="N">RNA Helicases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051176" MajorTopicYN="N">beta Catenin</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">LncRNA MALAT1</Keyword><Keyword MajorTopicYN="N">MRNA decay</Keyword><Keyword MajorTopicYN="N">Pyroptosis</Keyword><Keyword MajorTopicYN="N">SIRT6</Keyword><Keyword MajorTopicYN="N">UPF1</Keyword><Keyword MajorTopicYN="N">Viral myocarditis</Keyword><Keyword MajorTopicYN="N">Wnt/β-catenin signal pathway</Keyword></KeywordList><CoiStatement><b>Declarations</b> <b>Conflict of interest</b> The authors declare that they have no competing interests. <b>Ethical Approval and Consent to Participate</b> The experimental design was approved by the Ethics Committee of Hunan Children’s Hospital (Approval no. KYSQ-2022–304). All experiments involving mice were conducted based on the instructions on the Guide for Care and Use of Laboratory Animals issued by the National Institutes of Health. <b>Consent for Publication</b> Not applicable.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>18</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>5</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39367210</ArticleId><ArticleId IdType="doi">10.1007/s12012-024-09922-w</ArticleId><ArticleId IdType="pii">10.1007/s12012-024-09922-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tschope, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hubner, N., Kelle, S., Klingel, K., Maatz, H., Parwani, A. S., Spillmann, F., Starling, R. C., Tsutsui, H., Seferovic, P., &amp; Van Linthout, S. (2021). Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions. Nature Reviews Cardiology, 18, 169–193.</Citation><ArticleIdList><ArticleId IdType="pubmed">33046850</ArticleId><ArticleId IdType="doi">10.1038/s41569-020-00435-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Golpour, A., Patriki, D., Hanson, P. J., McManus, B., &amp; Heidecker, B. (2021). Epidemiological impact of myocarditis. Journal of Clinical Medicine, 10, 603.</Citation><ArticleIdList><ArticleId IdType="pubmed">33562759</ArticleId><ArticleId IdType="pmc">7915005</ArticleId><ArticleId IdType="doi">10.3390/jcm10040603</ArticleId></ArticleIdList></Reference><Reference><Citation>Olejniczak, M., Schwartz, M., Webber, E., Shaffer, A., &amp; Perry, T. E. (2020). Viral myocarditis-incidence, diagnosis and management. Journal of Cardiothoracic and Vascular Anesthesia, 34, 1591–1601.</Citation><ArticleIdList><ArticleId IdType="pubmed">32127272</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2019.12.052</ArticleId></ArticleIdList></Reference><Reference><Citation>Carai, P., Gonzalez, L. F., Van Bruggen, S., Spalart, V., De Giorgio, D., Geuens, N., Martinod, K., Jones, E. A. V., &amp; Heymans, S. (2023). Neutrophil inhibition improves acute inflammation in a murine model of viral myocarditis. Cardiovascular Research, 118, 3331–3345.</Citation><ArticleIdList><ArticleId IdType="pubmed">35426438</ArticleId><ArticleId IdType="doi">10.1093/cvr/cvac052</ArticleId></ArticleIdList></Reference><Reference><Citation>Favere, K., Bosman, M., Klingel, K., Heymans, S., Van Linthout, S., Delputte, P. L., De Sutter, J., Heidbuchel, H., &amp; Guns, P. J. (2021). Toll-like receptors: Are they taking a toll on the heart in viral myocarditis? Viruses, 13, 1003.</Citation><ArticleIdList><ArticleId IdType="pubmed">34072044</ArticleId><ArticleId IdType="pmc">8227433</ArticleId><ArticleId IdType="doi">10.3390/v13061003</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, C., Xiong, Y., Zeng, L., Peng, Z., Liu, Z., Zhan, H., &amp; Yang, Z. (2020). The role of non-coding RNAs in viral myocarditis. Frontiers in Cellular and Infection Microbiology, 10, 312.</Citation><ArticleIdList><ArticleId IdType="pubmed">32754448</ArticleId><ArticleId IdType="pmc">7343704</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2020.00312</ArticleId></ArticleIdList></Reference><Reference><Citation>Arun, G., Aggarwal, D., &amp; Spector, D. L. (2020). MALAT1 long non-coding RNA: Functional implications. Noncoding RNA, 6, 22.</Citation><ArticleIdList><ArticleId IdType="pubmed">32503170</ArticleId><ArticleId IdType="pmc">7344863</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, J., Sun, J., &amp; Zhou, X. (2019). Protective functions of myricetin in LPS-induced cardiomyocytes H9c2 cells injury by regulation of MALAT1. European Journal of Medical Research, 24, 20.</Citation><ArticleIdList><ArticleId IdType="pubmed">31027517</ArticleId><ArticleId IdType="pmc">6485133</ArticleId><ArticleId IdType="doi">10.1186/s40001-019-0378-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, J., &amp; Xu, C. (2021). LncRNA MALAT1-deficiency restrains lipopolysaccharide (LPS)-induced pyroptotic cell death and inflammation in HK-2 cells by releasing microRNA-135b-5p. Renal Failure, 43, 1288–1297.</Citation><ArticleIdList><ArticleId IdType="pubmed">34503385</ArticleId><ArticleId IdType="pmc">8439250</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2021.1974037</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue, Y., Ke, J., Zhou, X., Chen, Q., Chen, M., Huang, T., Lin, F., &amp; Chen, F. (2022). Knockdown of LncRNA MALAT1 alleviates coxsackievirus B3-induced acute viral myocarditis in mice via inhibiting Th17 cells differentiation. Inflammation, 45, 1186–1198.</Citation><ArticleIdList><ArticleId IdType="pubmed">35088199</ArticleId><ArticleId IdType="doi">10.1007/s10753-021-01612-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanathan, M., Porter, D. F., &amp; Khavari, P. A. (2019). Methods to study RNA-protein interactions. Nature Methods, 16, 225–234.</Citation><ArticleIdList><ArticleId IdType="pubmed">30804549</ArticleId><ArticleId IdType="pmc">6692137</ArticleId><ArticleId IdType="doi">10.1038/s41592-019-0330-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaath, H., Vishnubalaji, R., Elango, R., Kardousha, A., Islam, Z., Qureshi, R., Alam, T., Kolatkar, P. R., &amp; Alajez, N. M. (2022). Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches. Seminars in Cancer Biology, 86, 325–345.</Citation><ArticleIdList><ArticleId IdType="pubmed">35643221</ArticleId><ArticleId IdType="doi">10.1016/j.semcancer.2022.05.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao, Z. T., Yang, Y. M., Sun, M. M., He, Y., Liao, L., Chen, K. S., &amp; Li, B. (2022). New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer. Cancer Communications, 42, 117–140.</Citation><ArticleIdList><ArticleId IdType="pubmed">35019235</ArticleId><ArticleId IdType="pmc">8822594</ArticleId><ArticleId IdType="doi">10.1002/cac2.12254</ArticleId></ArticleIdList></Reference><Reference><Citation>Andjus, S., Morillon, A., &amp; Wery, M. (2021). From yeast to mammals, the nonsense-mediated mRNA decay as a master regulator of long non-coding RNAs functional trajectory. Noncoding RNA, 7, 44.</Citation><ArticleIdList><ArticleId IdType="pubmed">34449682</ArticleId><ArticleId IdType="pmc">8395947</ArticleId></ArticleIdList></Reference><Reference><Citation>He, J., &amp; Ma, X. (2021). Interaction between LncRNA and UPF1 in tumors. Frontiers in Genetics, 12, 624905.</Citation><ArticleIdList><ArticleId IdType="pubmed">33732285</ArticleId><ArticleId IdType="pmc">7959175</ArticleId><ArticleId IdType="doi">10.3389/fgene.2021.624905</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, S. R., Pratt, G. A., Martinez, F. J., Yeo, G. W., &amp; Lykke-Andersen, J. (2015). Target discrimination in nonsense-mediated mRNA decay requires Upf1 ATPase activity. Molecular Cell, 59, 413–425.</Citation><ArticleIdList><ArticleId IdType="pubmed">26253027</ArticleId><ArticleId IdType="pmc">4673969</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2015.06.036</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, L., Geng, Y., Feng, R., Zhu, Q., Miao, B., Cao, J., &amp; Fei, S. (2017). The human RNA surveillance factor UPF1 modulates gastric cancer progression by targeting long non-coding RNA MALAT1. Cellular Physiology and Biochemistry, 42, 2194–2206.</Citation><ArticleIdList><ArticleId IdType="pubmed">28942451</ArticleId><ArticleId IdType="doi">10.1159/000479994</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, G., Chen, H., Liu, H., Zhang, W., &amp; Zhou, J. (2021). Emerging roles of SIRT6 in human diseases and its modulators. Medicinal Research Reviews, 41, 1089–1137.</Citation><ArticleIdList><ArticleId IdType="pubmed">33325563</ArticleId><ArticleId IdType="doi">10.1002/med.21753</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, Z., Li, P., Ge, J., &amp; Li, H. (2022). SIRT6 in aging, metabolism, inflammation and cardiovascular diseases. Aging &amp; Disease, 13, 1787–1822.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2022.0413</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, X., Liu, H., Brooks, A., Xu, S., Luo, J., Steiner, R., Mickelsen, D. M., Moravec, C. S., Jeffrey, A. D., Small, E. M., &amp; Jin, Z. G. (2022). SIRT6 mitigates heart failure with preserved ejection fraction in diabetes. Circulation Research, 131, 926–943.</Citation><ArticleIdList><ArticleId IdType="pubmed">36278398</ArticleId><ArticleId IdType="pmc">9669223</ArticleId><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318988</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, M., Wang, X., Xie, Y., Xie, Y., Zhang, X., Zou, Y., Ge, J., &amp; Chen, R. (2013). Initial weight and virus dose: Two factors affecting the onset of acute coxsackievirus B3 myocarditis in C57BL/6 mouse–a histopathology-based study. Cardiovascular Pathology, 22, 96–101.</Citation><ArticleIdList><ArticleId IdType="pubmed">22784985</ArticleId><ArticleId IdType="doi">10.1016/j.carpath.2012.06.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, H., Diao, D., Shi, Z., Zhu, X., Gao, Y., Gao, S., Liu, X., Wu, Y., Rudolph, K. L., Liu, G., Li, T., &amp; Ju, Z. (2016). SIRT6 controls hematopoietic stem cell homeostasis through epigenetic regulation of Wnt signaling. Cell Stem Cell, 18, 495–507.</Citation><ArticleIdList><ArticleId IdType="pubmed">27058938</ArticleId><ArticleId IdType="doi">10.1016/j.stem.2016.03.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, L., Luo, R., Li, J., Wang, D., Zhang, Y., Liu, L., Zhang, N., Xu, X., Lu, B., &amp; Zhao, K. (2020). beta-catenin promotes NLRP3 inflammasome activation via increasing the association between NLRP3 and ASC. Molecular Immunology, 121, 186–194.</Citation><ArticleIdList><ArticleId IdType="pubmed">32244067</ArticleId><ArticleId IdType="doi">10.1016/j.molimm.2020.02.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Sozzi, F. B., Gherbesi, E., Faggiano, A., Gnan, E., Maruccio, A., Schiavone, M., Iacuzio, L., &amp; Carugo, S. (2022). Viral myocarditis: Classification, diagnosis, and clinical implications. Frontiers in Cardiovascular Medicine, 9, 908663.</Citation><ArticleIdList><ArticleId IdType="pubmed">35795363</ArticleId><ArticleId IdType="pmc">9250986</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2022.908663</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, M., Chippa, V. and An, J. (2024). Viral Myocarditis, in StatPearls, Treasure Island (FL) ineligible companies. Disclosure: Venu Chippa declares no relevant financial relationships with ineligible companies. Disclosure: Jason An declares no relevant financial relationships with ineligible companies.</Citation></Reference><Reference><Citation>Schultheiss, H. P., Baumeier, C., Aleshcheva, G., Bock, C. T., &amp; Escher, F. (2021). Viral myocarditis-from pathophysiology to treatment. Journal of Clinical Medicine, 10, 5240.</Citation><ArticleIdList><ArticleId IdType="pubmed">34830522</ArticleId><ArticleId IdType="pmc">8623269</ArticleId><ArticleId IdType="doi">10.3390/jcm10225240</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhan, A., Soleimani, M., &amp; Mandal, S. S. (2017). Long noncoding RNA and cancer: A new paradigm. Cancer Research, 77, 3965–3981.</Citation><ArticleIdList><ArticleId IdType="pubmed">28701486</ArticleId><ArticleId IdType="pmc">8330958</ArticleId><ArticleId IdType="doi">10.1158/0008-5472.CAN-16-2634</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan, H., &amp; Bu, P. (2021). Non-coding RNA in cancer. Essays in Biochemistry, 65, 625–639.</Citation><ArticleIdList><ArticleId IdType="pubmed">33860799</ArticleId><ArticleId IdType="pmc">8564738</ArticleId><ArticleId IdType="doi">10.1042/EBC20200032</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, M., Lu, H., Liu, J., Wu, S., Kim, P., &amp; Zhou, X. (2022). lncRNAfunc: A knowledgebase of lncRNA function in human cancer. Nucleic Acids Research, 50, D1295–D1306.</Citation><ArticleIdList><ArticleId IdType="pubmed">34791419</ArticleId><ArticleId IdType="doi">10.1093/nar/gkab1035</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, Q., &amp; Wang, Y. (2020). Long noncoding RNA MALAT1 regulates apoptosis in ischemic stroke by sponging miR-205-3p and modulating PTEN expression. American Journal of Translational Research, 12, 2738–2748.</Citation><ArticleIdList><ArticleId IdType="pubmed">32655805</ArticleId><ArticleId IdType="pmc">7344059</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoshnam, S. E., Moalemnia, A., Anbiyaee, O., Farzaneh, M., &amp; Ghaderi, S. (2023). LncRNA MALAT1 and ischemic stroke: Pathogenesis and opportunities. Molecular Neurobiology, 61, 4369–4380.</Citation><ArticleIdList><ArticleId IdType="pubmed">38087169</ArticleId><ArticleId IdType="doi">10.1007/s12035-023-03853-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, M., Gu, H., Xu, W., &amp; Zhou, X. (2016). Down-regulation of lncRNA MALAT1 reduces cardiomyocyte apoptosis and improves left ventricular function in diabetic rats. International Journal of Cardiology, 203, 214–216.</Citation><ArticleIdList><ArticleId IdType="pubmed">26512840</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2015.10.136</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, X. M., Zhang, Z., Zhong, J., Li, N., Wang, T., Wang, L., &amp; Zhang, Q. (2022). Long non-coding RNA MALAT1 modulates myocardial ischemia-reperfusion injury through the PI3K/Akt/eNOS pathway by sponging miRNA-133a-3p to target IGF1R expression. European Journal of Pharmacology, 916, 174719.</Citation><ArticleIdList><ArticleId IdType="pubmed">34968461</ArticleId><ArticleId IdType="doi">10.1016/j.ejphar.2021.174719</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang, Y., Tian, S., Pan, Y., Li, W., Wang, Q., Tang, Y., Yu, T., Wu, X., Shi, Y., Ma, P., &amp; Shu, Y. (2020). Pyroptosis: A new frontier in cancer. Biomedicine &amp; Pharmacotherapy, 121, 109595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.109595</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao, Z., Zhu, Y., Yang, P., Chen, Z., Xia, Y., Qiao, C., Liu, W., Deng, H., Li, J., Ning, P., &amp; Wang, Z. (2022). Pyroptosis in inflammatory diseases and cancer. Theranostics, 12, 4310–4329.</Citation><ArticleIdList><ArticleId IdType="pubmed">35673561</ArticleId><ArticleId IdType="pmc">9169370</ArticleId><ArticleId IdType="doi">10.7150/thno.71086</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue, R. C., Lu, S. Z., Luo, Y., Wang, T., Liang, H., Zeng, J., Liu, J., &amp; Hu, H. X. (2019). Calpain silencing alleviates myocardial ischemia-reperfusion injury through the NLRP3/ASC/Caspase-1 axis in mice. Life Sciences, 233, 116631.</Citation><ArticleIdList><ArticleId IdType="pubmed">31278945</ArticleId><ArticleId IdType="doi">10.1016/j.lfs.2019.116631</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, A., Sun, W., &amp; Mou, F. (2021). lncRNA-MALAT1 promotes high glucose-induced H9C2 cardiomyocyte pyroptosis by downregulating miR-141-3p expression. Molecular Medicine Reports, 23, 259.</Citation><ArticleIdList><ArticleId IdType="pubmed">33576445</ArticleId><ArticleId IdType="pmc">7893681</ArticleId><ArticleId IdType="doi">10.3892/mmr.2021.11898</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia, P., Wu, N., Jia, D., &amp; Sun, Y. (2019). Downregulation of MALAT1 alleviates saturated fatty acid-induced myocardial inflammatory injury via the miR-26a/HMGB1/TLR4/NF-kappaB axis. Diabetes, Metabolic Syndrome and Obesity, 12, 655–665.</Citation><ArticleIdList><ArticleId IdType="pubmed">31123414</ArticleId><ArticleId IdType="pmc">6511247</ArticleId><ArticleId IdType="doi">10.2147/DMSO.S203151</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitiello, M., Zullo, A., Servillo, L., Mancini, F. P., Borriello, A., Giovane, A., Della Ragione, F., D’Onofrio, N., &amp; Balestrieri, M. L. (2017). Multiple pathways of SIRT6 at the crossroads in the control of longevity, cancer, and cardiovascular diseases. Ageing Research Reviews, 35, 301–311.</Citation><ArticleIdList><ArticleId IdType="pubmed">27829173</ArticleId><ArticleId IdType="doi">10.1016/j.arr.2016.10.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, Y., Zhang, J., Xu, D., Peng, Y., Jin, Y., &amp; Zhang, L. (2021). SIRT6-specific inhibitor OSS-128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress. Molecular Medicine Reports, 23, 367.</Citation><ArticleIdList><ArticleId IdType="pubmed">33760202</ArticleId><ArticleId IdType="pmc">7986000</ArticleId><ArticleId IdType="doi">10.3892/mmr.2021.12006</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonas, K., Calin, G. A., &amp; Pichler, M. (2020). RNA-binding proteins as important regulators of long non-coding RNAs in cancer. International Journal of Molecular Sciences, 21, 2969.</Citation><ArticleIdList><ArticleId IdType="pubmed">32340118</ArticleId><ArticleId IdType="pmc">7215867</ArticleId><ArticleId IdType="doi">10.3390/ijms21082969</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin, H., Ni, H., Liu, Y., Yuan, Y., Xi, T., Li, X., &amp; Zheng, L. (2020). RNA-binding proteins in tumor progression. Journal of Hematology &amp; Oncology, 13, 90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-020-00927-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang, J., Lu, D., &amp; Xu, A. (2020). The interaction of circRNAs and RNA binding proteins: An important part of circRNA maintenance and function. Journal of Neuroscience Research, 98, 87–97.</Citation><ArticleIdList><ArticleId IdType="pubmed">30575990</ArticleId><ArticleId IdType="doi">10.1002/jnr.24356</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, Y., Xu, W., &amp; Zhou, R. (2021). NLRP3 inflammasome activation and cell death. Cellular &amp; Molecular Immunology, 18, 2114–2127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00740-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, Y., Gu, R., Shen, Z., &amp; Ye, Y. (2023). MALAT1 knockdown alleviates myocardial injury in mice with severe acute pancreatitis via the miR-374a/Sp1/Wnt/beta-catenin pathway. American Journal of Translational Research, 15, 3928–3941.</Citation><ArticleIdList><ArticleId IdType="pubmed">37434842</ArticleId><ArticleId IdType="pmc">10331685</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>